Kingfisher Towers remains an address, combining luxury, history, and an elite lifestyle, while continuing to redefine ...

BRIDGEWATER, N.J., and BENGALURU, India, Jan. 9, 2025 /PRNewswire/ --Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: ...

Biotechnology company Biocon Ltd stated on Thursday (January 2) that its wholly owned subsidiary, Biocon Pharma Ltd, has acquired permission from the National Medical Products Administration (NMPA ...

Biotechnology firm BioconLtd on Thursday (January 2) announced that its wholly owned subsidiary, Biocon Pharma Ltd, has received approval from the National Medical Products Administration (NMPA) in ...

Total business grows 16.9% to Rs 5.08 lakh crore Vs Rs 4.34 lakh crore Gross advances increase 21.2% to Rs 2.29 lakh crore Vs Rs 1.89 lakh crore ...

Biocon Ltd has hired more top executives in its generics business, Maninder Kapoor Puri, head of human resources said. “As Biocon's generics business grows in key markets and secures approvals ...

Biocon’s stock jumped on December 24 after the United States Food and Drug Administration (USFDA) and the European Union provided positive updates. The USFDA released an Establishment Inspection ...

Biocon rallied 4.63% to Rs 344.80 after it received an establishment inspection report (EIR) with a voluntary action indicated (VAI) status from the US drug regulator, for API facility located at ...

The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight management, Biocon Ltd said in a regulatory ...

Biocon and Zentiva receive EU approval for generic versions of Victoza (diabetes) and Saxenda (weight management). This marks a significant step in providing affordable treatment options for patients.